|
MIT World™ is a free and open site that provides on-demand video of significant public events at MIT. This is a video lecture of a talk by Daniel Vasella, Chairman of Novartis. As CEO, Vasella created the Novartis Institute for BioMedical Research and moved the company’s research headquarters to Cambridge, Massachusetts, to be closer to top scientific talent as well as patient and hospital networks. In this lecture, Daniel Vasella declines to discuss it in a systematic way, and instead, focuses on a case study of one of his company’s flagship pharmaceuticals, Gleevec. The discovery, development and marketing of this drug, which fights the rare chronic myeloid leukemia (CML), may point to some of the things Novartis does right, suggests Vasella.
|
